People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Selventa, Inc. | — | Other Health Care | Series A | $5.5M | $100.2M | 2010 |
| Twister Biotech, Inc. | — | Biotechnology | Seed | $1.6M | $3.9M | 2023 |
Michael Pavia at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Pavia on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Grey | 1 | 10 |
| Noubar Afeyan | 1 | 9 |
| Mitchell Bloom | 1 | 6 |
| Arnold Levine | 1 | 4 |
| Chris Thomajan | 1 | 3 |
| Sean McCarthy | 1 | 3 |
| Evan Davies | 1 | 3 |
| David De Graaf | 1 | 3 |
| Christopher Coker | 1 | 2 |
| Jim Matheson | 1 | 2 |
| Chris Varma | 1 | 1 |
| Alex Steven | 1 | 1 |
| Mark Matovich | 1 | 1 |
| Lynn Zechiedrich | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.